| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PNAS..10915894C |
| P356 | DOI | 10.1073/PNAS.1208324109 |
| P932 | PMC publication ID | 3465417 |
| P698 | PubMed publication ID | 22967508 |
| P5875 | ResearchGate publication ID | 230831985 |
| P50 | author | Steen Dissing | Q58216798 |
| P2093 | author name string | Hong Ji | |
| Yin Zhang | |||
| Renhai Cao | |||
| Yihai Cao | |||
| Yuping Sun | |||
| Xiaojuan Yang | |||
| Katerina Tritsaris | |||
| Ninghan Feng | |||
| Patrik Andersson | |||
| Anker Jon Hansen | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 | ||
| Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis | Q24681191 | ||
| Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation | Q28285842 | ||
| Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis | Q28587821 | ||
| The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. | Q30499283 | ||
| Real-time imaging reveals the single steps of brain metastasis formation | Q33519908 | ||
| Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. | Q34066152 | ||
| Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo | Q34098683 | ||
| Molecular mechanisms of lymphangiogenesis in health and disease | Q34710547 | ||
| Lymphangiogenesis and cancer metastasis | Q34770288 | ||
| VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. | Q35682284 | ||
| Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis | Q36012194 | ||
| Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. | Q36014526 | ||
| First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours | Q36612618 | ||
| Vascular endothelial growth factor C induces angiogenesis in vivo. | Q36734917 | ||
| Tumor-derived lymphangiogenic factors and lymphatic metastasis. | Q36955392 | ||
| Why and how do tumors stimulate lymphangiogenesis? | Q37354197 | ||
| Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases | Q37378717 | ||
| Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model | Q37428993 | ||
| PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells | Q39433494 | ||
| Hypoxia-induced metastasis model in embryonic zebrafish | Q39624502 | ||
| Intravital imaging of metastatic behavior through a mammary imaging window. | Q39919364 | ||
| The implications of angiogenesis for the biology and therapy of cancer metastasis | Q40394139 | ||
| Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. | Q40459739 | ||
| Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis | Q44166133 | ||
| Immunological consequences of macrophage-mediated clearance of apoptotic cells | Q45227897 | ||
| Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients | Q70537350 | ||
| In vivo absence of synergism between fibroblast growth factor-2 and vascular endothelial growth factor | Q77510939 | ||
| Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis | Q81004145 | ||
| Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody | Q81230337 | ||
| Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action | Q82312177 | ||
| Mouse corneal lymphangiogenesis model | Q84261553 | ||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | collaboration | Q1145523 |
| lymphangiogenesis | Q6708231 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 15894-15899 | |
| P577 | publication date | 2012-09-11 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis | |
| P478 | volume | 109 |
| Q42630200 | A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer. |
| Q47759308 | Angiogenesis and lymphangiogenesis in corneal transplantation-A review |
| Q92316582 | Angiogenesis, Lymphangiogenesis, and the Immune Response in South African Preeclamptic Women Receiving HAART |
| Q59789310 | Application of atomic force microscopy in cancer research |
| Q36937771 | Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future |
| Q58333841 | Cardiac lymphatics in health and disease |
| Q64968736 | Characterization of multi-cellular dynamics of angiogenesis and vascular remodelling by intravital imaging of the wounded mouse cornea. |
| Q51688281 | Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia. |
| Q34621884 | Clinical significance of fibroblast growth factor (FGF) expression in colorectal cancer |
| Q39834125 | Collaborative effects between the TNFα-TNFR1-macrophage axis and the VEGF-C-VEGFR3 signaling in lymphangiogenesis and metastasis |
| Q37170738 | Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer. |
| Q92715171 | Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma |
| Q40073882 | Development of the LYVE-1 Gene with An Acidic-amino-acid-rich (AAAR) Domain in Evolution Is Associated with Acquisition of Lymph Nodes and Efficient Adaptive Immunity. |
| Q42049687 | Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer |
| Q37388064 | Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors |
| Q49384248 | Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling |
| Q36898186 | Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A) |
| Q41202031 | Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: a longitudinal study |
| Q37341131 | Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis |
| Q88639628 | Endothelial Metabolic Control of Lymphangiogenesis |
| Q38887615 | FGFs: crucial factors that regulate tumour initiation and progression. |
| Q37603125 | Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer |
| Q58698791 | Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer |
| Q35962330 | Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma |
| Q38386206 | High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer. |
| Q47310869 | How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development |
| Q92554910 | Human adipose-derived stem cells support lymphangiogenesis in vitro by secretion of lymphangiogenic factors |
| Q33563488 | Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib |
| Q40886377 | Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer |
| Q34105706 | Interplay between Inflammatory Responses and Lymphatic Vessels |
| Q41633824 | Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice |
| Q57817458 | Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 |
| Q38190359 | Lymphangiogenesis and lymphatic vessel remodelling in cancer |
| Q33819978 | Lymphangiogenesis in Oral Squamous Cell Carcinoma: Correlation with VEGF-C Expression and Lymph Node Metastasis. |
| Q38192927 | Lymphangiogenic factors, mechanisms, and applications |
| Q90482453 | Lymphatic Vessel Network Structure and Physiology |
| Q38831331 | Lymphatics, Cancer and Zebrafish. |
| Q36637462 | MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis |
| Q52682124 | Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy. |
| Q33624824 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis |
| Q88647024 | Mesenchymal stem cells promote lymphangiogenic properties of lymphatic endothelial cells |
| Q42016960 | MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes |
| Q39293053 | Modeling Proteolytically Driven Tumor Lymphangiogenesis. |
| Q38412048 | Nintedanib in non-small cell lung cancer: from preclinical to approval |
| Q54441414 | Overexpression of VEGF-C attenuates chronic high salt intake-induced left ventricular maladaptive remodeling in spontaneously hypertensive rats. |
| Q64069619 | Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinoma |
| Q37281490 | Pericyte-fibroblast transition promotes tumor growth and metastasis. |
| Q50419857 | Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. |
| Q46410306 | Prevention of Postsurgical Lymphedema by 9-cis Retinoic Acid |
| Q50506414 | Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis. |
| Q38977239 | RAS interaction with PI3K p110α is required for tumor-induced angiogenesis. |
| Q38080371 | Regulation of lymphatic vascular morphogenesis: Implications for pathological (tumor) lymphangiogenesis |
| Q37191031 | Slug promoted vasculogenic mimicry in hepatocellular carcinoma |
| Q92918329 | TGFBIp mediates lymphatic sprouting in corneal lymphangiogenesis |
| Q47241129 | TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides. |
| Q54321573 | TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling. |
| Q38498207 | Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor |
| Q38263008 | Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium |
| Q35829182 | The -553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women |
| Q37690651 | The Pleiotropic Role of L1CAM in Tumor Vasculature |
| Q34633821 | The biophysical property of A549 cells transferred by VEGF-D. |
| Q91725337 | The impact of exercise on growth factors (VEGF and FGF2): results from a 12-month randomized intervention trial |
| Q38689578 | The lymphatic system and pancreatic cancer |
| Q38840344 | The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production |
| Q38131800 | Tissue engineering and regeneration of lymphatic structures |
| Q37162383 | Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination |
| Q27021391 | Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer |
| Q64063128 | Tumor-Associated Lymphatic Vessel Features and Immunomodulatory Functions |
| Q46871186 | Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. |
| Q36901201 | VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis |
| Q38232368 | VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs |
| Q53056691 | Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer. |
| Q36740927 | siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice |
Search more.